Home ➤ Life Science ➤ Biotechnology ➤ Peptide Synthesis Market
Peptide Synthesis Market
Published date: Feb 2024 • Formats:
Request Sample Schedule a Call

Global Peptide Synthesis Market By Product Type(Equipment, Reagents & Consumables, Other Product Types) By Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), Hybrid Technology) By Application-Therapeutics(Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT (Gastrointestinal Disorders), Infectious Diseases, Pain, Dermatology, CNS, Renal, Others) By Diagnosis, By Research, By End-use (Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organization/Contract Research Organization, Academic & Research Institutes) By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024–2033

  • Published date: Feb 2024
  • Report ID: 18814
  • Number of Pages: 393
  • Format:
  • keyboard_arrow_up
    • 1. Peptide Synthesis Market Introduction
      • 1.1. Definition
      • 1.2. Taxonomy
      • 1.3. Research Scope
    • 2. Executive Summary
      • 2.1. Key Findings by Major Segments
      • 2.2. Top strategies by Major Players
    • 3. Global Peptide Synthesis Market Overview
      • 3.1. Peptide Synthesis Market Dynamics
        • 3.1.1. Drivers
        • 3.1.2. Opportunities
        • 3.1.3. Restraints
        • 3.1.4. Challenges
      • 3.2. PESTLE Analysis
      • 3.3. Opportunity Map Analysis
      • 3.4. PORTER'S Five Forces Analysis
      • 3.5. Market Competition Scenario Analysis
      • 3.6. Product Life Cycle Analysis
      • 3.7. Opportunity Orbits
      • 3.8. Manufacturer Intensity Map
    • 4. Global Peptide Synthesis Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
      • 4.1. Global Peptide Synthesis Market Analysis by Type: Introduction
      • 4.2. Market Size and Forecast by Region
      • 4.3. Under 75%
      • 4.4. 75% to 85%
      • 4.5. Above 85%
    • 5. Global Peptide Synthesis Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
      • 5.1. Global Peptide Synthesis Market Analysis by Application: Introduction
      • 5.2. Market Size and Forecast by Region
      • 5.3. Commercial
      • 5.4. Academic Research
    • 6. Global Peptide Synthesis Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
      • 6.1. North America
        • 6.1.1. North America Peptide Synthesis Market: Regional Trend Analysis
          • 6.1.1.1. US
          • 6.1.1.2. Canada
          • 6.1.1.3. Mexico
      • 6.2. Europe
        • 6.2.1. Europe Peptide Synthesis Market: Regional Trend Analysis
          • 6.2.1.1. Germany
          • 6.2.1.2. France
          • 6.2.1.3. UK
          • 6.2.1.4. Russia
          • 6.2.1.5. Italy
          • 6.2.1.6. Rest of Europe
      • 6.3. Asia-Pacific
        • 6.3.1. Asia-Pacific Peptide Synthesis Market: Regional Trend Analysis
          • 6.3.1.1. China
          • 6.3.1.2. Japan
          • 6.3.1.3. Korea
          • 6.3.1.4. India
          • 6.3.1.5. Rest of Asia
      • 6.4. Latin America
        • 6.4.1. Latin America Peptide Synthesis Market: Regional Trend Analysis
          • 6.4.1.1. Brazil
          • 6.4.1.2. Argentina
          • 6.4.1.3. Rest of Latin America
      • 6.5. Middle East and Africa
        • 6.5.1. Middle East and Africa Peptide Synthesis Market: Regional Trend Analysis
          • 6.5.1.1. GCC
          • 6.5.1.2. South Africa
          • 6.5.1.3. Israel
          • 6.5.1.4. Rest of MEA
    • 7. Global Peptide Synthesis Market Competitive Landscape, Market Share Analysis, and Company Profiles
        • 7.1. Market Share Analysis
        • 7.2. Company Profiles
        • 7.3. Bachem
          • 7.3.1. Company Overview
          • 7.3.2. Financial Highlights
          • 7.3.3. Product Portfolio
          • 7.3.4. SWOT Analysis
          • 7.3.5. Key Strategies and Developments
        • 7.4. PolyPeptide
          • 7.4.1. Company Overview
          • 7.4.2. Financial Highlights
          • 7.4.3. Product Portfolio
          • 7.4.4. SWOT Analysis
          • 7.4.5. Key Strategies and Developments
        • 7.5. GL Biochem
          • 7.5.1. Company Overview
          • 7.5.2. Financial Highlights
          • 7.5.3. Product Portfolio
          • 7.5.4. SWOT Analysis
          • 7.5.5. Key Strategies and Developments
        • 7.6. Xinbang
          • 7.6.1. Company Overview
          • 7.6.2. Financial Highlights
          • 7.6.3. Product Portfolio
          • 7.6.4. SWOT Analysis
          • 7.6.5. Key Strategies and Developments
        • 7.7. Hybio
          • 7.7.1. Company Overview
          • 7.7.2. Financial Highlights
          • 7.7.3. Product Portfolio
          • 7.7.4. SWOT Analysis
          • 7.7.5. Key Strategies and Developments
        • 7.8. US VPeptides
          • 7.8.1. Company Overview
          • 7.8.2. Financial Highlights
          • 7.8.3. Product Portfolio
          • 7.8.4. SWOT Analysis
          • 7.8.5. Key Strategies and Developments
        • 7.9. Thermofischer
          • 7.9.1. Company Overview
          • 7.9.2. Financial Highlights
          • 7.9.3. Product Portfolio
          • 7.9.4. SWOT Analysis
          • 7.9.5. Key Strategies and Developments
        • 7.10. ScinoPharm
          • 7.10.1. Company Overview
          • 7.10.2. Financial Highlights
          • 7.10.3. Product Portfolio
          • 7.10.4. SWOT Analysis
          • 7.10.5. Key Strategies and Developments
        • 7.11. Genscript
          • 7.11.1. Company Overview
          • 7.11.2. Financial Highlights
          • 7.11.3. Product Portfolio
          • 7.11.4. SWOT Analysis
          • 7.11.5. Key Strategies and Developments
        • 7.12. AnaSpec
          • 7.12.1. Company Overview
          • 7.12.2. Financial Highlights
          • 7.12.3. Product Portfolio
          • 7.12.4. SWOT Analysis
          • 7.12.5. Key Strategies and Developments
        • 7.13. New England Peptide
          • 7.13.1. Company Overview
          • 7.13.2. Financial Highlights
          • 7.13.3. Product Portfolio
          • 7.13.4. SWOT Analysis
          • 7.13.5. Key Strategies and Developments
        • 7.14. CPC Scientific
          • 7.14.1. Company Overview
          • 7.14.2. Financial Highlights
          • 7.14.3. Product Portfolio
          • 7.14.4. SWOT Analysis
          • 7.14.5. Key Strategies and Developments
        • 7.15. JPT
          • 7.15.1. Company Overview
          • 7.15.2. Financial Highlights
          • 7.15.3. Product Portfolio
          • 7.15.4. SWOT Analysis
          • 7.15.5. Key Strategies and Developments
        • 7.16.21st Century Bio
          • 7.16.1. Company Overview
          • 7.16.2. Financial Highlights
          • 7.16.3. Product Portfolio
          • 7.16.4. SWOT Analysis
          • 7.16.5. Key Strategies and Developments
        • 7.17. LifeTein
          • 7.17.1. Company Overview
          • 7.17.2. Financial Highlights
          • 7.17.3. Product Portfolio
          • 7.17.4. SWOT Analysis
          • 7.17.5. Key Strategies and Developments
        • 7.18. Proimmune
          • 7.18.1. Company Overview
          • 7.18.2. Financial Highlights
          • 7.18.3. Product Portfolio
          • 7.18.4. SWOT Analysis
          • 7.18.5. Key Strategies and Developments
        • 7.19. Biomatik
          • 7.19.1. Company Overview
          • 7.19.2. Financial Highlights
          • 7.19.3. Product Portfolio
          • 7.19.4. SWOT Analysis
          • 7.19.5. Key Strategies and Developments
    • 8. Assumptions and Acronyms
    • 9. Research Methodology
    • 10. Contact
  • settingsSettings

Related Reports

Our Clients

  • Our Clients
Inquiry Before Buying

Peptide Synthesis Market
  • 18814
  • Feb 2024
    • ★★★★★
      ★★★★★
    • (109)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
Multi User
$8,000
$5,999
USD / per unit
save 28%
Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999) Buy Now ($ 5,999) Buy Now ($ 6,999)
Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options